{"name":"Edwards Lifesciences Corporation","slug":"edwards","ticker":"EW","exchange":"NYSE","domain":"edwards.com","description":"Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland.","hq":"Irvine, CA","founded":0,"employees":"16000","ceo":"Bernard Zovighian","sector":"MedTech / Cardiovascular","stockPrice":81.67,"stockChange":0.28,"stockChangePercent":0.34,"marketCap":"$47.0B","metrics":{"revenue":6303499776,"revenueGrowth":16.7,"grossMargin":77.9,"rdSpend":1079200000,"netIncome":1073500000,"cash":2938000000,"dividendYield":0,"peRatio":44.1,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Edwards Lifesciences Reports Fourth Quarter and Full Year 2023 Earnings","summary":"Edwards Lifesciences reported fourth quarter and full year 2023 earnings, with revenue of $1.64 billion and adjusted earnings per share of $1.43.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Edwards Lifesciences Acquires CardiAQ Valve Technologies","summary":"Edwards Lifesciences acquired CardiAQ Valve Technologies, a developer of transcatheter mitral valve replacement systems.","drugName":"","sentiment":"positive"},{"date":"2023-06-30","type":"regulatory","headline":"Edwards Lifesciences Receives FDA Approval for SAPIEN 3 Ultra Transcatheter Heart Valve","summary":"Edwards Lifesciences received FDA approval for the SAPIEN 3 Ultra transcatheter heart valve, a next-generation valve designed for patients with severe aortic stenosis.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOOXFwbkgzUmdvYmNyTGN2UW4zdUNGNUs5WUo2b0llVU00UVJuRnh0Q08xOHlHdGxKYXdFUWxBRVRldG5nZ3RyWHR6WGNvbVZfUjIwX3NabDBXSU4zUDVIMWRCS09xbGpmN1E5T25IcWdBWWJPa3VHa3NWbzVMdlI3cnVlVGw4S2E0NEFuRzN6Y2F5NkFwSmRaLUJCSEpoMTBoRkdGcFNqellTVTJYc1VsSHdnS1J6R0JlSlh2TnY4YzllRGFkcmlWTFU4Vm02MFhnb1F0a2phdw?oc=5","date":"2026-04-02","type":"pipeline","source":"MarketBeat","summary":"Edwards Lifesciences Corporation $EW Shares Sold by Nisa Investment Advisors LLC - MarketBeat","headline":"Edwards Lifesciences Corporation $EW Shares Sold by Nisa Investment Advisors LLC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOUEp3VzFyaDNFZERZVjF1Q2pWWU82ZHNWcGwtdHRHWHZlaGFBOHhoWlotWWtLc1I5NnlGUVREbmx6Zmg3ei1lWU1HNUN3UUJqVVVqeW9fOTl5TlZLNUdjQmxTbEFkbzBoY2owcVRRcWNOdEpzUHh5SDh0OWtpeDhUZzUxb19TcnJIMlNxRmN3RmRaT0E2ckxlMjIzcHhqZw?oc=5","date":"2026-03-27","type":"earnings","source":"inkl.com","summary":"What to Expect From Edwards Lifesciences' Next Quarterly Earnings Report - inkl.com","headline":"What to Expect From Edwards Lifesciences' Next Quarterly Earnings Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNSmpXQmZkMUZEOFVJQXVZbTlnVXVIX2hGZzRSb0NjNURvN3lySm5jaGhBWGJXemxQZW1TNVRnMm9oVl9UQWFLSXM1cmhmdDZINWxDMW9DVTJ2dzBpMWM5aUxxMHpXR3B2UnRRVG03ZDAxaU5Tb0l4b3hKcXRsVFFIeC0zbkZaM1Rib1FPa0tGNTJ1MnF2Z3pkWjJCNnZBZTRNU010VGxZM2FER0Q5TnhvQ3JnUklaOEVNbFZrQklzV3BNeDBhMUMxNTdNLV9OSlpGUzBILTZxR3hWM2ZVS0Y0cV9XTkw0bllIVW9KZDd1dVVwcnJiNnRxYWNmbUd2WHB2S0pv?oc=5","date":"2026-03-17","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Plus Therapeutics (PSTV) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Plus Therapeutics (PSTV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbUJkdWVHQmZyWUM0b0VrZ3V6a2Z5cEljRi1YX0hvX3l3THVCZzg4ZnVLMVRHUEU3aF9NOFN6dU5DVWhtZXBacm1jWGUtUWpuWURYWVFfNGRRdGczQ2FnSFdyRm5ha21VNVRWcUExVmNvRnR5dVR6MWp2Y3JhNXByWXg4ay1fazJ3Qldj?oc=5","date":"2026-03-16","type":"pipeline","source":"Seeking Alpha","summary":"Edwards Lifesciences: More Appeal For The Heart (NYSE:EW) - Seeking Alpha","headline":"Edwards Lifesciences: More Appeal For The Heart (NYSE:EW)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPOGU0ZHU1Wm5YR0JhaWplTkRSRlVaTkVjbl82WkRCZ3Z3N3MwcmZMSW1OeE80d2ZibFNwUzNMdnJJQXJYc0FMeHhoUlhwcGUwcVRSZG9QYlg2Q1g0RUZTWjdfSTlPMmVIMHdpcmMwRVk5T3pvdEE0X24wT21EOUdrazNRVzI3czdlS1luZlBCN0dnbHlQODFnRndZMFIwamx6?oc=5","date":"2026-03-05","type":"pipeline","source":"Finviz","summary":"Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - Finviz","headline":"Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOVTc0cnJaUkxtUFFfdkhFazl6R0pjMl83ZDBhV2xpVGY0MWdvMUtxUzR0ZmJvNkVtY0xlVXhWMFJRRXhKdWxiTFlZSFIxUXBMdThmeEdxS2NPc1V2RjRaODBDQkNEZVpJcXhGYlEwOHVodlg5b0F6MGJnaXdYRE5xSWNCU09PbkJMRWxrQ2IxV0JTU2FaR1dhS0NGajJqR0o1TTVDRS1RcHpqdHFLUVZtSm5RNUNrN1JmUXlyWmhfX2JjZw?oc=5","date":"2026-03-04","type":"pipeline","source":"TradingView","summary":"Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - TradingView","headline":"Here's Why You Should Retain Revvity Stock in Your Portfolio for Now","sentiment":"neutral"},{"date":"2026-02-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNemJEZDZ3SGZFeGJkZzVFdlZyYm5SdEJQMTBsQ2lRVnZaaWJweVBtNm9BSllBejZoYjM5Vm9PWnVaY19xNHB3dktnVGdJMjVob2RqMHpuRjlXMjdBd3IwTkJBTEZ3LWYwUnZ1MEVheENydU4tcnhVQUx1V3gxeUxnVmlnQTVTdnQ1OERyUU84cXBHeHlnN3pncWczOThpMTZwbkdqYjVLc3pIWU1wdTU4RXBIYzIyaEtoZnhn?oc=5","date":"2026-02-20","type":"pipeline","source":"Fierce Pharma","summary":"Novo Nordisk nominates 2 industry vets to board in latest leadership shake-up - Fierce Pharma","headline":"Novo Nordisk nominates 2 industry vets to board in latest leadership shake-up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQSi1vV3lfd3NNSVNXeVZfTHNYd3VGTktaVHpDczUtNi1aQzY2dDdHZFlETkoxRS1kQ3RvTk9hTjB5Ymh0SWJJNk1VdDdPdzZQSFBqaXBYaTM4Y0d5c0liVkltU0ZnZlVxYmpEWEVJVnJiMU95VEJ0M3h0c0tOMWREY1BUR01pbFJKSFQ5eHUxekJwSS04eGVHRHlVWkIxU2cycVJDUndobU1BWEp1eVFRT0VtNm92bFFKOUFYYmlITQ?oc=5","date":"2026-02-16","type":"deal","source":"marketscreener.com","summary":"Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal - marketscreener.com","headline":"Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE4zOU1zT01IMG93R2NSMVZZMUVTS0l6N1Bybksza0FjM2U4N2JILVllMWVuZjRNMlpZYjI1a1Q1YTNpN09lUWdWek9ENWUwbktFampnWkl2dU5iend4SW0ydDZVWFdWUmYweFc3bUVtS1R5WDFsdGc?oc=5","date":"2026-01-15","type":"earnings","source":"Modern Healthcare","summary":"JPM 2026, Day 4: Clover predicts a profit, plans tech investments - Modern Healthcare","headline":"JPM 2026, Day 4: Clover predicts a profit, plans tech investments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOa3gtLWhJV2M3RE9LanJvRXZUalJ5ZjJfek5zekV1ZTE2RkJNVFpwTEx1UXlRUV9pbkZMOEhHWmkxX1hMenczdWxBSEh4eHZwcWpRS3o1ZXR6clE0b1RTYzdra0NwNkIzdVJlVnAxTklzSjhnSjM5T1RDZGVCRnF0dF82TkJyOGxhemh2b3BGUVdEM0c1Mk5qVmxfRnl6LVN1eG0zaDZrQkxTTXZjZUZIZTFoS1F6ZHhpLWMxdXVvZmladw?oc=5","date":"2026-01-07","type":"pipeline","source":"AD HOC NEWS","summary":"The Truth About Edwards Lifesciences (EW): Quiet Medical Giant, Loud Stock Moves - AD HOC NEWS","headline":"The Truth About Edwards Lifesciences (EW): Quiet Medical Giant, Loud Stock Moves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPMGVTX1h4QjFvRjZVTkdQLXd1WlhGS1NsTDFDdkdtSVFJZlJZOUhYaS1ZQm1BSVpMUXJPeG5xUnkzMUhEbW01YURNaU5NVlVseVZUSDZ6QjQ5QWhXTE04aWpRWmY0aUZ6eTE2U0JSSkhrenJlU05tbG9VWG1tcFZLLTBnNy0?oc=5","date":"2025-10-17","type":"earnings","source":"Yahoo Finance","summary":"Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings - Yahoo Finance","headline":"Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPWjk1VXZ5bngtUGtTaWtFM0FfWmlWMWlkdWJ5eTY3blc5cXI0dDNQT1lxdWsyWi1oWUk0TDc0dkZ2RVNpVDl2TDF5TGpaMk8yaHZkcTBsdXVqbmd4WjZNdTVqWThJSFQwdW8zb0Z4RHR2cGJWbGs3TUV4SXJmQVR3dHV2Vmh6SFZBb0lOajFPTHh4dmVl?oc=5","date":"2025-10-14","type":"pipeline","source":"Seeking Alpha","summary":"Edwards Lifesciences: Inflection Incoming, But When? (NYSE:EW) - Seeking Alpha","headline":"Edwards Lifesciences: Inflection Incoming, But When? (NYSE:EW)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":4,"keyCompetitors":["Medtronic","Boston Scientific","Abbott Laboratories"],"therapeuticFocus":["Cardiovascular","Critical Care"],"financials":{"source":"sec_edgar+yahoo","revenue":6067600000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":6067600000,"period":"2025-12-31"},{"value":5439500000,"period":"2024-12-31"},{"value":1354400000,"period":"2024-09-30"},{"value":1369400000,"period":"2024-06-30"},{"value":1329900000,"period":"2024-03-31"},{"value":6004800000,"period":"2023-12-31"}],"grossProfit":4733400000,"grossProfitHistory":[{"period":"2025-12-31","value":4733400000},{"period":"2024-12-31","value":4322000000},{"period":"2023-12-31","value":4031600000},{"period":"2022-12-31","value":3740300000}],"rdSpend":1079200000,"rdSpendHistory":[{"period":"2025-12-31","value":1079200000},{"period":"2024-12-31","value":1053000000},{"period":"2023-12-31","value":962900000},{"period":"2022-12-31","value":843600000}],"sgaSpend":2085200000,"operatingIncome":1636200000,"operatingIncomeHistory":[{"period":"2025-12-31","value":1636200000},{"period":"2024-12-31","value":1480100000},{"period":"2023-12-31","value":1486200000},{"period":"2022-12-31","value":1539100000}],"netIncome":1073500000,"netIncomeHistory":[{"period":"2025-12-31","value":1073500000},{"period":"2024-12-31","value":4174600000},{"period":"2023-12-31","value":1402400000},{"period":"2022-12-31","value":1521900000}],"eps":1.83,"epsHistory":[{"period":"2025-12-31","value":1.83},{"period":"2024-12-31","value":6.97},{"period":"2023-12-31","value":2.3},{"period":"2022-12-31","value":2.44}],"cash":2938000000,"cashHistory":[{"period":"2025-12-31","value":2938000000},{"period":"2024-12-31","value":3045200000},{"period":"2023-12-31","value":1132300000},{"period":"2022-12-31","value":769000000}],"totalAssets":13697200000,"totalLiabilities":3359600000,"totalDebt":705400000,"equity":10337600000,"operatingCashflow":1595200000,"operatingCashflowHistory":[{"period":"2025-12-31","value":1595200000},{"period":"2024-12-31","value":542300000},{"period":"2023-12-31","value":895800000},{"period":"2022-12-31","value":1218200000}],"capex":-260200000,"capexHistory":[{"period":"2025-12-31","value":-260200000},{"period":"2024-12-31","value":-282400000},{"period":"2023-12-31","value":-266300000},{"period":"2022-12-31","value":-264800000}],"freeCashflow":1335000000,"dividendsPaid":null,"buybacks":-893400000,"employees":16000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":null,"ebitda":null,"period":"2026-03-31","revenue":null,"epsBasic":0.66,"netIncome":null,"rdExpense":null,"epsDiluted":0.66,"grossProfit":null,"operatingIncome":null},{"sga":602900000,"ebit":27400000,"ebitda":70100000,"period":"2025-12-31","revenue":1569600000,"epsBasic":0.16,"netIncome":91200000,"rdExpense":267700000,"epsDiluted":0.16,"grossProfit":1226600000,"operatingIncome":370300000},{"sga":514600000,"ebit":425100000,"ebitda":464300000,"period":"2025-09-30","revenue":1553100000,"epsBasic":0.5,"netIncome":291100000,"rdExpense":280700000,"epsDiluted":0.5,"grossProfit":1207900000,"operatingIncome":425100000},{"sga":502000000,"ebit":430900000,"ebitda":469000000,"period":"2025-06-30","revenue":1532200000,"epsBasic":0.57,"netIncome":329800000,"rdExpense":276200000,"epsDiluted":0.56,"grossProfit":1187800000,"operatingIncome":430900000},{"sga":465700000,"ebit":409900000,"ebitda":446500000,"period":"2025-03-31","revenue":1412700000,"epsBasic":0.61,"netIncome":358000000,"rdExpense":254600000,"epsDiluted":0.61,"grossProfit":1111100000,"operatingIncome":409900000},{"sga":491900000,"ebit":441100000,"ebitda":483700000,"period":"2024-12-31","revenue":1385800000,"epsBasic":null,"netIncome":385600000,"rdExpense":271100000,"epsDiluted":null,"grossProfit":1093600000,"operatingIncome":353300000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":81.67,"previousClose":81.39,"fiftyTwoWeekHigh":87.89,"fiftyTwoWeekLow":72.3,"fiftyTwoWeekRange":"72.3 - 87.89","fiftyDayAverage":81.68,"twoHundredDayAverage":81.22,"beta":0.87,"enterpriseValue":43895762944,"forwardPE":24.3,"priceToBook":4.59,"priceToSales":7.46,"enterpriseToRevenue":6.96,"enterpriseToEbitda":23.06,"pegRatio":1.92,"ebitda":1903600000,"ebitdaMargin":30.2,"freeCashflow":902137472,"operatingCashflow":1358599936,"totalDebt":702899968,"debtToEquity":6.8,"currentRatio":4.42,"returnOnAssets":8.3,"returnOnEquity":10.5,"analystRating":"1.7 - Buy","recommendationKey":"buy","numberOfAnalysts":27,"targetMeanPrice":97.15,"targetHighPrice":110,"targetLowPrice":84,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.2,"institutionHeldPercent":88.7,"sharesOutstanding":575800000,"floatShares":574026536,"sharesShort":10538452,"shortRatio":1.92,"shortPercentOfFloat":1.8,"epsTrailing":1.85,"epsForward":3.36,"revenuePerShare":10.81,"bookValue":17.8,"officers":[{"age":57,"name":"Mr. Bernard J. Zovighian","title":"CEO & Director"},{"age":58,"name":"Mr. Scott B. Ullem","title":"Corporate VP & CFO"},{"age":63,"name":"Mr. Donald E. Bobo Jr.","title":"Corporate Vice President of Strategy & Corporate Development"},{"age":46,"name":"Mr. Daveen  Chopra","title":"Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies"},{"age":54,"name":"Ms. Annette Maria Bruls","title":"Corporate Vice President of EMEA, Canada, & Latin America"},{"age":null,"name":"Mr. Joseph  Nuzzolese","title":"Corporate Vice President of Global Operations & Quality"},{"age":47,"name":"Mr. Andrew M. Dahl","title":"Principal Accounting Officer, Senior VP & Corporate Controller"},{"age":null,"name":"Dr. Todd  Brinton FACC, M.D.","title":"Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer"}],"industry":"Medical Devices","irWebsite":"http://ir.edwards.com/","website":"https://www.edwards.com","phone":"949 250 2500"}}